Evotec's CEO Explains Logic Behind Drug Discovery Pact With Novo Nordisk

 
• By Sten Stovall

Novo Nordisk's R&D pact with Evotec will open therapeutic possibilities for the Danish group in diabetes and obesity using small molecules, says Evotec's CEO.

Researchers
Novo Nordisk Is Tapping External Know-How with Its Evotec Pact • Source: Shutterstock

More from Strategy

More from Business